Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis.

ABSTRACT:

Background

MetS is associated with greater morbidity and mortality in relation to a number of malignancies, but its association with ovarian cancer remains contested. The present study was a systematic review and meta-analysis of case-control and cohort studies examining the association between MetS and ovarian cancer risk.

Methods

The study was registered on the PROSPERO platform in January 2023 (CRD42023391830). Up until February 13, 2023, a complete search was undertaken in PubMed, EMBASE, Web of Science, the Cochrane Library, and ClinicalTrials. On the basis of inclusion and exclusion criteria, eligible studies for meta-analysis were screened to determine the association between MetS and ovarian cancer risk.

Results

Five studies were included in total, including t

SUBMITTER: Chen Z 

PROVIDER: S-EPMC10484223 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature